Companies / Nabriva Therapeutics plc
Nabriva Therapeutics plc
NBRVCIK 1641640
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 28, 2021 | Schroeder Theodore R CEO | Buy Open-market buy | Ordinary Shares | $57.3K | +100K +44.27% | 325,879 | medium |
| Sep 14, 2021 | Schroeder Theodore R CEO | Buy Open-market buy | Ordinary Shares | $56.5K | +50K +28.27% | 226,875 | medium |
| Feb 6, 2021 | Schroeder Theodore R CEO | Other Withheld for taxes | Ordinary Shares | $7.8K | -3K -1.48% | 178,985 | low |
| Jan 29, 2022 | Schroeder Theodore R CEO | Other Withheld for taxes | Ordinary Shares | $4.8K | -11K -3.31% | 314,736 | low |
| Dec 27, 2021 | Naftzger J. Christopher Executive | Buy Open-market buy | Ordinary Shares | $4.1K | +7K | 7,000 | low |
| Feb 6, 2021 | Gelone Steven P. Executive | Other Withheld for taxes | Ordinary Shares | $3.2K | -1K -1.41% | 76,924 | low |
| Feb 6, 2021 | Crotty Robert Executive | Other Withheld for taxes | Ordinary Shares | $2.5K | -870 -2.04% | 41,819 | low |
| Aug 2, 2022 | Burgess Daniel D Director | Sell Open-market sale | Ordinary Shares | $2.2K | -11K -52.20% | 10,384 | low |